PF-Atlas › Clinical Trials › NCT01455675
Efficacy Study of IgY in Cystic Fibrosis Patients
IgY · Phase 3
Registry ID
NCT01455675
Phase
Phase 3
Status
Completed
Drug / intervention
IgY
Sponsor
Mukoviszidose Institut gGmbH
Start
2011-10
Enrollment
164
Locations
42
About this trial
The purpose of this study is to prolong the time to reinfection with Pseudomonas aeruginosa after successfully treated acute or intermittent infection.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT01455675 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.